Evidence map›Paper›PMID 37779195›Full record

ArticleCancer cell international2023

HK3 stimulates immune cell infiltration to promote glioma deterioration.

Shupeng Li, Ziwei Li, Xinyu Wang, Junzhe Zhong, Daohan Yu, Hao Chen, Wenbin Ma, Lingling Liu, Minghuang Ye, Ruofei Shen and 3 more

Open access · goldAbstract read
In one paragraph

Article in Cancer cell international, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
1.6field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Review
  10. Article
  11. Article
  12. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 2 institutions in 1 country.

Shupeng Li *Department of Neurosurgery, The Second Affiliated Hospital of Harbin Medical University, Harbin, China.
Ziwei Li *Department of Neurosurgery, The Second Affiliated Hospital of Harbin Medical University, Harbin, China.
Xinyu WangDepartment of Neurosurgery, The Second Affiliated Hospital of Harbin Medical University, Harbin, China.
Junzhe ZhongDepartment of Neurosurgery, The Second Affiliated Hospital of Harbin Medical University, Harbin, China.
Daohan YuDepartment of Neurosurgery, The Second Affiliated Hospital of Harbin Medical University, Harbin, China.
Hao ChenDepartment of Neurosurgery, The Second Affiliated Hospital of Harbin Medical University, Harbin, China.
Wenbin MaDepartment of Neurosurgery, The Second Affiliated Hospital of Harbin Medical University, Harbin, China.
Lingling LiuDepartment of Clinical Medical Record, The Second Affiliated Hospital of Harbin Medical University, Harbin, China.
Minghuang YeDepartment of Neurosurgery, The Second Affiliated Hospital of Harbin Medical University, Harbin, China.
Ruofei ShenDepartment of Neurosurgery, The Second Affiliated Hospital of Harbin Medical University, Harbin, China.
Chuanlu JiangDepartment of Neurosurgery, The Second Affiliated Hospital of Harbin Medical University, Harbin, China. jcl6688@163.com.
Xiangqi MengDepartment of Neurosurgery, The Second Affiliated Hospital of Harbin Medical University, Harbin, China. neptune_mxq@126.com.
Jinquan CaiDepartment of Neurosurgery, The Second Affiliated Hospital of Harbin Medical University, Harbin, China. caijinquan666777@126.com.
Harbin Medical University · CNSecond Affiliated Hospital of Harbin Medical University · CN

Funding

Central Government Supporting Local University Reform and Development Fund for Excellent Youth Talents 0202-300011190006China Postdoctoral Science Foundation 2019M660074China Postdoctoral Science Foundation 2020T130157Harbin Medical University Scientific Research Innovation Fund YJSCX2020-38HYDHeilongjiang Postdoctoral Science Foundation LBH-TZ2113Heilongjiang Postdoctoral Science Foundation LBH-Z19029Heilongjiang Provincial Key R & D Project GA21C002National Natural Science Foundation of China 81972817National Natural Science Foundation of China 82003022National Natural Science Foundation of China 82073298Natural Science Foundation of Heilongjiang Province LH2022H022
6 · The paper itself

Abstract

backgroundGlioma is the most common and lethal type of brain tumor, and it is characterized by unfavorable prognosis and high recurrence rates. The reprogramming of energy metabolism and an immunosuppressive tumor microenvironment (TME) are two hallmarks of tumors. Complex and dynamic interactions between neoplastic cells and the surrounding microenvironment can generate an immunosuppressive TME, which can accelerate the malignant progression of glioma. Therefore, it is crucial to explore associations between energy metabolism and the immunosuppressive TME and to identify new biomarkers for glioma prognosis.

methodsIn our work, we analyzed the co-expression relationship between glycolytic genes and immune checkpoints based on the transcriptomic data from The Cancer Genome Atlas (TCGA) and Chinese Glioma Genome Atlas (CGGA) and found the correlation between HK3 expression and glioma tumor immune status. To investigate the biological role of HK3 in glioma, we performed bioinformatics analysis and established a mouse glioblastoma (GBM) xenograft model.

resultsOur study showed that HK3 significantly stimulated immune cell infiltration into the glioma TME. Tissue samples with higher HK3 expressive level showed increasing levels of immune cells infiltration, including M2 macrophages, neutrophils, and various subtypes of activated memory CD4

conclusionThe present work mainly concentrated on the biological role of HK3 in glioma and offered a novel insight of HK3 regulating the activation of immune cells in the glioma microenvironment. These findings could provide a new theoretical evidence for understanding the metabolic molecular within the glioma microenvironment and identifying new therapeutic targets.

Indexed as

GliomaGlycolysisHK3Immune infiltrationPrognosis

Identifiers

PMID37779195
PMCPMC10543879
OpenAlexW4387232966

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.